Hepatitis Forums
Advanced Liver Disease Main Forums => Advanced Liver Disease => Topic started by: Hep Editors on May 26, 2017, 10:08:40 am
-
An experimental liver cancer treatment of radioactive beads did not lead to a greater survival benefit compared with the standard treatment, but it was superior in measures of safety and quality of life, MedPage Today reports.
A randomized Phase III trial measured the radioactive-bead selective internal radiation therapy (SIRT) against the standard of care, Nexavar (sorafenib), among 467 French people with advanced hepatocellular carcinoma (HCC, the most common form of liver cancer) or inoperable HCC who had failed two rounds of transarterial chemoembolization (TACE) treatment.
Read more...
https://www.hepmag.com/article/treating-liver-cancer-radioactive-beads-improves-quality-life